相关实验视频

Updated: May 1, 2026

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion

Published on: February 17, 2013

大脑小血 perfusion 是一个诊断,但不是预后,标志着帕金森主导型多系统缩

Kenta Shiina¹, Taiji Tsunemi¹, Nobutaka Hattori¹

¹Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Parkinsonism & related disorders

|April 27, 2024

概括

在多系统性缩症帕金森主导型 (MSA-P) 患者中,可以检测到大脑流,而没有动脉,使用N-异烯-p-[¹²³I]胺胺 (¹²³I-IMP) SPECT. 这一发现并不表明神经预后较差.

科学领域:

神经学神经学
放射学放射学是一门学科.
医疗成像医学成像

背景情况:

多重系统缩 (MSA) 呈现出各种神经系统症状.
MSA被分为帕金森主导型 (MSA-P) 或大脑动主导型 (MSA-C) 类型.
在MSA-P中,I-IMP SPECT显示出早期发现小脑功能障碍的前景.

研究的目的:

调查小脑低输液是否影响MSA-P.的临床特征.
为了确定在没有小脑症状的MSA-P患者中是否存在hyperfusion.
为了确定小脑低流是否会影响MSA-P的预后.

主要方法:

15年来88名MSA患者的回顾性分析.
使用I-IMP SPECT进行临床数据收集和小脑输液评估.
3D-SSP技术和Z分数分析的应用.

主要成果:

与对照组 (p=0.0017) 相比,在MSA-P患者没有心力衰竭 (MSA-Pp) 中观察到小脑输液减少.
¹²³I-IMP SPECT显示了与健康对照对MSA-Pp进行区分的适度能力 (AUC=0.6832).
带有低输液的MSA-Pp趋向于更好的预后,尽管在统计学上并不显著.

结论:

¹²³I-IMP SPECT对于检测MSA-Pp中的亚临床小脑功能障碍很有价值.
在MSA-P中,大脑小细胞输液不足与较差的神经预后无关.

关键词:

多重系统缩多重系统缩单光子发射计算断层扫描 (SPECT) 技术

更多相关视频

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

A Gravity-Fed Transcardial Perfusion Method for Histologic Analysis of the Mouse Central Nervous System

A Gravity-Fed Transcardial Perfusion Method for Histologic Analysis of the Mouse Central Nervous System

Published on: January 21, 2022

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...